Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Mar 1.

Published in final edited form as: Clin Immunol. 2019 Jan 9;200:55–63. doi: 10.1016/j.clim.2019.01.002

Table 1.

Lymphocyte Studies

	Patient	Reference Range
WBC	5,200 cells/μL	4.0-12.0
Absolute Lymph Count	2122	1.0-4.4
CD8⁺	119 cells/μL (5.6%)^*	490-1,300
CD4⁺	963 cells/μL (45.4%)	700-2,200
CD3⁺	1,133 cells/μL (53.4%)^*	1,400-3,700
CD19⁺	526 cells/μL (24.8%)	390-1,400
CD16⁺/56⁺	429 cells/μL (20.2%)	130-720
CD4⁺/CD45RA⁺	13.0% T cells	9.5-41.9%
CD4⁺/CD45RO⁺	84.0% T cells	16.5-42.2%
TCR/αβ	93.2% T cells	>85%
TCR/γδ	8.4% T cells^*	0.5-6%
IgD⁺/CD27⁺	54.0% CD20+ cells^*	4.9-14.2%
IgD⁻/CD27⁺	3.1% CD20+ cells	2.9-9.2%
CD38^hi/IgM^hi	0.2% CD20+ cells	0.3-9.2% of B cells
CD38^hi/IgM^lo	0.4% CD20+ cells	0.1-4.7% of B cells

^*

Denotes abnormal value